Analyst consensus rating
SpyGlass Pharma Analyst Rating: Strong Buy
SGP is rated Strong Buy by 6 analysts with a $44.00 target. As of 2026-08-23.
Direct answer
SpyGlass Pharma's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $44.00.
Forecast evidence checked August 23, 2026.
Get free SpyGlass Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $26.51
- Average price target
- $44.00
- High price target
- $62.00
- Low price target
- $37.00
- Low target gap
- +39.6%
- Target upside
- +66%
- High target gap
- +133.9%
- Target range width
- 94.3%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- August 23, 2026
- Valid through
- August 30, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for SpyGlass Pharma?
SpyGlass Pharma has a verified Strong Buy consensus. The same dataset has an average price target of $44.00.
How far are SpyGlass Pharma's low and high targets from the recorded price?
The low target implies +39.6%, while the high target implies +133.9%.
How many analysts are included in SpyGlass Pharma's consensus?
The verified consensus includes 6 analysts.
How is SpyGlass Pharma's target upside or downside calculated?
The average target of $44.00 is divided by the recorded price of $26.51, then one is subtracted to produce +66%. This does not guarantee a future return.
When was SpyGlass Pharma's analyst forecast verified?
The data was verified on 2026-08-23. The dataset is valid through 2026-08-30.